Imperative Care Unveils New Company Structure

August 10, 2023—Imperative Care, Inc., a medical technology company developing treatments for stroke and other ischemic diseases, announced a new organizational structure for the company that is designed to accelerate growth across its businesses.

The company, which is based in Campbell, California, was cofounded in 2016 by neurointerventionist L. Nelson “Nick” Hopkins, MD, and Fred Khosravi. Dr. Hopkins is Founder and Chief Scientific Officer of the Jacobs Institute in Buffalo, New York. Mr. Khosravi is Chairman and CEO of Imperative Care, which is the 21st company founded by him and Incept LLC, a medical technology accelerator.

The company’s original focus on stroke care has expanded to the development of treatments for other ischemic diseases, such as pulmonary embolism and peripheral vascular disease.

As outlined in the company’s press release, Imperative Care is now the parent company of the following four business units:

• Imperative Care Stroke is focused on interventional treatments for patients with ischemic and hemorrhagic stroke.
• Imperative Care Vascular develops treatments for patients with vascular diseases, including pulmonary embolism.
• Kandu Health is a digital health company focused on remote support as for stroke recovery and postacute care.
• Telos Health uses robotics and automation to optimize vascular intervention with the goal of making stroke and vascular thrombectomies accessible to more patients.

According to the company, Imperative Care’s Zoom stroke solution incorporates innovations at every part of the ischemic stroke procedure—from access through clot capture—that are designed to allow physicians to achieve complete clot removal and full reperfusion of the target vessel within 10 minutes. The company has four FDA 510(k)-cleared product platforms, as well as a stroke technology development pipeline.

Imperative Care Vascular has two FDA-cleared products that are designed to remove a wide range of clots in the peripheral arteries and veins: the Symphony thrombectomy system for venous applications; and the Prodigy thrombectomy system for peripheral arterial applications. Prodigy is commercially available at select hospitals in the United States. Symphony’s targeted launch will be initiated in the coming months. Additionally, a pipeline of products is in development.

Imperative Care Vascular was formerly Truvic Medical, which was acquired in 2021.

Kandu Health’s digital health platform offers remote clinical support to stroke survivors in the first 90 days after a stroke. Support is tailored to each patient based on their individual needs and provided through licensed healthcare providers. The formation of Kandu Health was announced in February 2023.

Telos Health’s technology seeks to improve treatment speed, procedural consistency, and outcomes for stroke and vascular thrombectomies.

“Our vision for Imperative Care has always been to bring forward clinically meaningful innovations that are inspired and shaped by physicians and unmet clinical needs impacting patient care,” commented Mr. Khosravi in the company’s press release. “We believe that the patient is the only constant in the chain of care from detection through treatment and recovery. Through connected innovation, we can look holistically at what the patient needs across the full continuum of care and achieve something meaningful for patients and their families.”

Dr. Hopkins added, “The advent of thrombectomy over the last few decades has brought one of the most powerful treatments in medicine to patients. But this incredible success has also resulted in a fragmented approach to acute stroke, with many companies focused on different approaches to clot removal. From its inception, Imperative Care has taken a unique approach from detection all the way through to treatment and post-acute care, with a focus on enabling a better recovery for survivors—holistically focusing on the patient rather than the disease alone.”